Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Supplying Medicines and Supplements to Algeria

A practical guide for Algerian importers, operators and hospital buyers who source from abroad, and for manufacturers and exporters worldwide selling into Algeria.

Algeria protects its local industry more than almost any other market: since 2009 it has banned importing generics that are produced locally. Imports complement local production rather than compete with it.

Rules adopted in October 2025 require an annual import programme approved by the ministry, and DataMatrix coding follows from 2027. The opportunity is in products Algeria doesn't make: specialised, hospital and oncology medicines.

Algeria at a glance

Who importsApproved pharmaceutical establishments only
Who holds the registrationA foreign marketing authorisation holder must appoint a local operator, with joint liability
The big restrictionNo imports of generics produced locally (since 2009); imports only to complement local production
Import programmeAn annual import programme approved by the ministry, under rules adopted in October 2025
Public buyerPCH, the central hospital pharmacy, runs national and international open tenders for hospital medicines

How to supply medicines to Algeria

  1. Check the product can be imported. If the generic is made locally, it can't be imported. Focus on products Algeria doesn't make.
  2. Appoint a local operator. A foreign marketing authorisation holder appoints a local operator, who shares liability.
  3. Register and plan imports. Register the product with a CTD dossier, CoPP and GMP evidence, and get it into the approved annual import programme.
  4. Supply. Approved importers for the private market, or PCH tenders for public hospitals. Plan for DataMatrix coding from 2027.

Temporary authorisations of up to a year cover serious diseases with no local equivalent, for products approved by a recognised authority such as the FDA. A 2024 list names 467 unregistered products that only PCH may import for public facilities. See named-patient and special import and government tender supply.

Supplements

Supplements follow food rules unless they contain medicinal ingredients or make medicinal claims. Confirm the classification with your importer before you print labels. We help brands get supplements made under their own label by GMP-certified contract manufacturers: see nutraceutical private label.

What people in Algeria search for

Semrush data from October 2026 shows strong supplement demand in French and Arabic: magnesium (about 12,100 searches a month), vitamin D (about 9,900 in French and 8,100 in Arabic), omega-3, B12, creatine, ashwagandha and collagen.

Supplements we can help you make

Because locally made generics can't be imported, imports are mainly specialised and hospital products. Some examples we list:

Documents to ask your supplier for

Not sure a supplier is genuine? Read how to verify a pharmaceutical supplier. For the neighbouring markets, see our Middle East and North Africa import guide.

Sourcing for Algeria?

Send the product, strength, quantity and the documents your regulator needs. We will match you with GMP-certified manufacturers and suppliers who can serve your market, wherever they are based.

Send your requirement Talk to our team

Frequently asked questions

Only if they are not produced locally. Since 2009 Algeria has banned importing generics that are made in the country.

Only approved pharmaceutical establishments. A foreign marketing authorisation holder must appoint a local operator, with joint liability.

New rules require an annual import programme approved by the ministry and allow imports only to complement local production. DataMatrix coding follows from 2027.

Temporary authorisations of up to a year cover serious diseases with no local equivalent, for products approved by a recognised authority such as the FDA. A 2024 list names 467 products that only PCH may import.

PCH, the central hospital pharmacy, through national and international open tenders.

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us